Cite
HARVARD Citation
Link, H. et al. (n.d.). 1696PA randomized, open-label, non-inferiority study comparing the efficacy and safety of lipegfilgrastim versus pegfilgrastim in elderly patients with aggressive B-cell non-Hodgkin lymphomas (B-NHL): AVOID neutropenia. Annals of oncology. p. . [Online].